URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://www.akampion.com/news/2022/03/tolerogenixx-receives-approval-to-start-phase-iib-trial-for-its-immune-tolerance-inducing-mic-lx-cell-therapy/ | 20% | Monthly | 2022-03-28 07:58 |
https://www.akampion.com/news/2022/03/omnix-medical-advances-novel-anti-infective-program-into-clinical-development/ | 20% | Monthly | 2022-03-16 08:58 |
https://www.akampion.com/news/2022/03/neonatal-diagnostics-company-infandx-ag-closes-oversubscribed-second-tranche-of-series-a/ | 20% | Monthly | 2022-03-15 08:59 |